Biomarkers are measurable and quantifiable biological indicators which are used in diagnosing or predicting disease, monitoring disease progression and also to indicate what treatment options will be most effective in an individual patient's case and estimate the treatment response. They play a role both in new drug R&D and in predicting the outcome of treatment. These are the important tools to understand disease mechanism, developing more effective treatments and improving the quality of patient care.
- Track 1-1 CNS drug development using biomarkers
- Track 2-2 Cerebrospinal fluid biomarkers
- Track 3-3 Biomarker challenges in rare diseases
- Track 4-4 Neuroimaging enrichment for CNS disease